1
2
3
We don't have analytics for this instrument yet. You can contribute!
Please log in and be the first author to write an article about this instrument!
DexCom, Inc. (NASDAQ)
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices for specific and permitted use cases, including non-medical device applications, medical device data analysis, integrated continuous glucose monitoring systems (iCGM) secondary display alarms, active patient monitoring, and treatment decisions; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was incorporated in 1999 and is headquartered in San Diego, California.
Horario de operaciones (UTC)
Abrir ahora
Cerrado
Cierre el
Apertura el
a las
-
El horario de apertura del mercado se indica según su zona horaria local
(UTC)
Ticker | DXCM |
Valor de contrato | 100 shares |
Apalancamiento máximo | 1:5 |
Historial de swaps
Fecha | Short Swap (%) | Long Swap (%) | No hay datos |
---|
Volumen mínimo de una transacción | 0.01 lotes |
Volumen máximo de una transacción | 100 lotes |
Margen de cobertura | 50% |